CD19 CAR T cells (CliniMACS Prodigy)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD19 CAR T cells (CliniMACS Prodigy), covering 2025-08-15 to 2025-08-15. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL [EARLY_Phase 1]